Comprehensive Clinical Trials: Trials of TODAY for...CURES for TOMORROW!
About
CCTLLC
  Clinical Trials
& Research
  News and
Articles
  Related
Links
  Contact
CCTLLC
CCTLLC: News & ArticlesComprehensive Clinical Trials, LLCAbout CCTLLCContact CCTLLC

For more information on any of Dr. Ackerman's publications below, please contact us directly.

  • “Ectopic Pregnancy”, Journal of American College of Obstetrics and Gynecology, 1983.

  • Reviewer for the Journal of American College of Obstetrics and Gynecology.

  • “Gynecologic Health Management of Cervical Ectopic Pregnancy”, 1983.

  • “Meningiomas and Pregnancy”, Journal of Reproductive Medicine, 1992.

  • Health Columnist for The Forum Newspaper, 1996.

  • Menopausal Editor for OB/GYN.NET, 1998.

  • “Response to Therapy with Once-Weekly Alendronate 70mg compared to Once-Weekly Risedronate 35mg in the Treatment of Postmenopausal Osteoporosis", Current Medical Research and Opinion, Merck & Co. Inc., 2004.

  • “A Study to Establish a Reference Range for Biochemical Markers of Bone Turnover in Healthy Postmenopausal Women: A Comparison of Oral Contraceptive Users and Non-Users”,

  • Foundation for Osteoporosis Research and Education, Merck & Co. Inc., 2004.

  • Abstract for North American Menopause Society (NAMS): “Biochemical Marker Reference Ranges in Healthy Premenopausal Woman; Oral Contraceptive Users Versus Nonusers” Poster Presentation.

  • Abstract for North American Menopause Society (NAMS): “Efficacy of 3 Doses of Estradiol Gel 0.1% in the Treatment of Vasomotor Symptoms and Vulvar Vaginal Atrophy” Poster Presentation.

  • Safety and Tolerability of 3 Doses of Estradiol Gel 0.1% in the Treatment of Menopausal Symptoms.

  • NAMS annual meeting 2007 Presentation.

  • Manuscript “Impact of treating overactive bladder with tolterodine extended release on sexual and emotional quality of life in sexually active women.”

  • “Efficacy of a human papillomavirus (HPV)-16/18 L1 virus-like particle (VLP) AS04 vaccine: a phase III randomized controlled trial in young women.” The Lancet.

  • “Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women”.

  • Abnormal Pap Smears

  • Abnormal Periods

  • Anemia

  • Bloating

  • Birth Control

  • Endometriosis

  • Female Sexual Issues, Decreased sex-drive

  • Gastroenterology diseases (GERD)

  • Heavy Menstrual Bleeding

  • HPV Prevention, Genital Warts

  • Hormonal Therapy

  • Hot Flushes

  • Orthopedic disease studies

  • Osteoporosis Prevention and Treatment

  • Overactive Bladder

  • Pain with Intercourse

  • Pelvic Pain

  • PMS

  • Pre/Post Menopausal Symptoms

  • Urinary Incontinence

  • Vaccines

  • Vaginal Dryness

  • Vaginal Pain

  • Vaginitis/Vaginal Infection

  • Vulvodynia

  • Weight Loss

 
 
 
 
home | NEW PATIENT FORM | please enjoy | privacy practices | join our team
Comprehensive Clinic Trials, LLC - Copyright 2008. All Rights Reserved.  ||   Create, Promote, Host at BYTEsize Marketing
~ SE HABLA ESPANOL ~